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Saporin-6 produced by the plant Saponaria officinalis
belongs to the family of single chain ribosome-inactivat-
ing proteins. It potently inhibits protein synthesis in
eukaryotic cells, by cleaving the N-glycosidic bond of a
specific adenine in 28 S rRNA, which results in the cell
death. Saporin-6 has also been shown to be active on
DNA and induces apoptosis. In the current study, we
have investigated the roles of rRNA depurination and
the activity of saporin-6 on genomic DNA in its cytotoxic
activity. The role of putative active site residues, Tyr72,
Tyr120, Glu176, Arg179, and Trp208, and two invariant res-
idues, Tyr16 and Arg24, proposed to be important for
structural stability of saporin-6, has been investigated
in its catalytic and cytotoxic activity. These residues
were mutated to alanine to generate seven mutants,
Y16A, R24A, Y72A, Y120A, E176A, R179A, and W208A. We
show that for the RNA N-glycosidase activity of sa-
porin-6, residues Tyr16, Tyr72, and Arg179 are absolutely
critical; Tyr120 and Glu176 can be partially dispensed
with, whereas Trp208 and Arg24 do not appear to be
involved in this activity. The residues Tyr72, Tyr120,
Glu176, Arg179, and Trp208 were found to be essential for
the genomic DNA fragmentation activity, whereas resi-
dues Tyr16 and Arg24 do not appear to be required for
the DNA fragmentation. The study shows that saporin-6
possesses two catalytic activities, namely RNA N-glyco-
sidase and genomic DNA fragmentation activity, and for
its complete cytotoxic activity both activities are
required.
Ribosome-inactivating proteins (RIPs)1 are toxic translation
inhibitors produced by plants and bacteria. RIPs have been
classified into two types; type I RIPs are composed of a single
polypeptide chain, whereas type II RIPs consist of two chains,
A and B, linked by a disulfide bond (1). Type I RIPs (e.g.
saporin, trichosanthin, and pokeweed antiviral protein) and
A-chain of type II RIPs (e.g. ricin and abrin) inhibit protein
synthesis by removing a specific adenine from 28 S rRNA of
eukaryotic ribosomes. The former also removes an equivalent
adenine residue, A2660, from 23 S rRNA of Escherichia coli
ribosomes (2). In both cases, the site of action is located in a
highly conserved, purine-rich stem and loop structure of rRNA
termed the -sarcin/ricin loop (3). The catalytic depurination
disrupts the binding of elongation factors to the ribosomes,
thus arresting protein synthesis at the translocation step (4).
Although the catalytic action carried out by all the RIPs is
identical, their activity on ribosomes from sources other than
eukaryotes are markedly different (1, 5). Differences in toxicity
of RIPs toward various cell lines, their different requirements
for cofactors, and variations in the minimal structure of the
adenine-containing loop that they can attack point to their
substantial diversity (6, 7). The study of molecules that bind
and inactivate RIPs has also suggested that local sequence/
structure variabilities exist among RIPs (8). The interest in
RIPs has gained a new momentum recently with the growing
evidence of their action on nonribosomal substrates (9–11).
Most of the novel enzymatic activities are related to a pre-
sumed RNase or DNase activity. Other enzymatic activities
reported for individual RIPs include phosphatase activity on
lipids, chitinase activity, and superoxide dismutase activity
(12–14). It has been shown that pokeweed antiviral protein
cleaves the double-stranded supercoiled DNA using the same
active site required to depurinate rRNA and that momordin
has intrinsic RNase activity (15, 16). A better understanding of
the catalytic mechanism of RIPs will be extremely useful in the
exploitation of their unique properties for diverse applications
like development of RIP-based immunotoxins, abortifacients,
and anti-HIV agents (17).
Saporin is a family of single-chain ribosome-inactivating pro-
teins present in abundance in the plant Saponaria officinalis
(18). Among RIPs, various peculiar features of saporin, in
terms of its remarkable stability and activity on a wide variety
of substrates, make it an interesting protein to study for struc-
ture-function relationships (19, 20). The crystal structure of
saporin-6 has been solved recently (21). The structure super-
imposition of saporin-6 has shown that corresponding to ricin
A-chain active site residues, the residues Tyr72, Tyr120, Glu176,
Arg179, and Trp208 constitute the active site of saporin-6 (21,
22).
In the present study, analytical mutagenesis of saporin-6,
the most active isoform, was carried out to study the role of
residues present in its active site. The active site residues
Tyr72, Tyr120, Glu176, Arg179, and Trp208 were mutated to ala-
nine, and the activities of the mutants were compared with the
wild type protein using various functional assays. An interest-
ing feature found in primary sequence alignment of RIPs was
the invariance of residues, tyrosine and arginine, correspond-
ing to position 21 and 29, respectively, in the ricin sequence. An
analysis of ricin-A chain structure showed that a central -he-
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lix is bent near its C terminus, and this bending allows the
catalytic residues, Glu177 and Arg180, to reach the solvent of the
active site cleft (23). This important helix bending disrupts
the normal -helical bonding pattern. However, the resulting
structure is stabilized by new hydrogen bonds to the side
chains of Tyr21 and Arg29. Alterations of these residues could
therefore affect the folding rate or thermodynamic stability of
the protein. In order to ascertain the role of corresponding
residues, Tyr16 and Arg24, in saporin-6, they were mutated to
alanine, and the mutants were analyzed for various functional
activities. Saporin-6 has been reported to contain DNA nucle-
ase activity, and recently saporin-L1 has been shown to act on
various forms of mammalian DNA (10, 24). DNA could be a
probable alternate polynucleotide substrate for RIPs within a
cell. In the present study, the effect of saporin-6 and the mu-
tants has been studied on genomic DNA of U937 cells. An
attempt has been made to correlate the cytotoxicity of saporin-6
with the effect of toxin action on DNA and RNA. Our study
shows that the cytotoxic activity of saporin is a cumulative
effect of its RNA N-glycosidase and DNA fragmentation
activity.
EXPERIMENTAL PROCEDURES
Construction of Saporin-6 Mutants—Saporin-6 is a protein consist-
ing of 253 amino acid residues. pSap-6 is a plasmid containing the
759-base pair saporin-6 gene cloned downstream of a T7 promoter in
bacterial expression vector pVex 11. pSap-6 was used as a template to
mutate the codons for active site residues Tyr72, Tyr120, Glu176, Arg179,
and Trp208 to that for alanine. Similarly, the codons for the invariant
residues Tyr16 and Arg24 were also mutated to that for alanine. All of
the mutations were carried out by oligonucleotide-mediated site-di-
rected mutagenesis (25). Uracil-containing DNA template was prepared
by infecting the CJ236 strain of E. coli cells with the recombinant phage
and growing it in the presence of uridine and chloramphenicol (25).
Mutagenesis was performed using the DNA primers JKB54, JKB55,
JKB56, JKB57, JKB58, JKB59, and JKB60 containing the mutations
Y16A, R24A, Y72A, Y120A, E176A, R179A, and W208A, respectively.
The sequences of various primers used are mentioned in Table I. The
primer extension products were transformed into E. coli strain DH5 by
standard methods. All mutations were confirmed by DNA sequencing
using the dideoxy chain termination method (26).
Expression and Purification of the Recombinant Proteins—Saporin-6
and the mutants were expressed in BL21 (DE3) strain of E. coli.
Bacterial cells were transformed with the desired construct and grown
in Super broth containing 100 g/ml ampicillin at 37 °C with shaking.
Saporin-6 and all of the mutants were found to accumulate in the form
of inclusion bodies, and they were purified using the procedure de-
scribed by Buchner et al. (27). Briefly, the resuspended cells were lysed
with lysozyme, and the membrane pellet was washed with Triton X-100
followed by several washings without Triton X-100. The inclusion body
pellet thus obtained was dissolved in guanidine hydrochloride and
reduced by adding dithioerythritol. Renaturation was carried out by
100-fold dilution of the protein in a refolding buffer containing L-argi-
nine and oxidized glutathione. After incubating at 10 °C for 48 h, the
renatured material was dialyzed against 20 mM acetate buffer, pH 4.5,
containing 100 mM urea. The dialyzed solution was loaded on an S-
Sepharose column and eluted using a 0–1.5 M gradient of NaCl in 20
mM acetate buffer, pH 4.5. Relevant fractions were pooled, concen-
trated, and purified to homogeneity by gel filtration chromatography on
a TSK 3000 column in PBS, pH 7.4.
Structural Characterization by Circular Dichroism—For CD spectral
analysis, 200 g of protein was dissolved in 3 ml of 10 mM sodium
phosphate buffer (pH 7.0), and spectra were recorded in the far-UV
range (200–250 nm) at room temperature, using a JASCO J710 spec-
tropolarimeter. A cell with a 1-cm optical path was used to record the
spectra at a scan speed of 50 nm/min with a sensitivity of 50 millide-
grees and a response time of 1 s. The sample compartment was purged
with nitrogen, and spectra were averaged over 10 scans. The results are
presented as mean residue ellipticity. Yang’s reference parameters
were used to perform secondary structure analyses from CD measure-
ments (28).
Specific RNA N-Glycosidase Activity of Saporin-6 and the Mutants—
The RNA N-glycosidase activity of saporin and its mutants was evalu-
ated as their ability to specifically depurinate 28 S rRNA and produce
a characteristic 390-base fragment on aniline treatment. Rabbit reticu-
locyte lysate was taken as the source of ribosomes and treated with
different concentrations of proteins at 30 °C for 0.5 h as described by
May et al. (29). The reaction was stopped by adding 10 l of 10% SDS
solution and 170 l of water and incubated at room temperature for 5
min. Total RNA was isolated using Trizol reagent as per the manufac-
turer’s instructions. The RNA pellet was dissolved in 20 l of water and
divided in two parts. To one part, 10 l of freshly prepared 2 M aniline-
acetate, pH 4.5, was added. The samples were incubated at 60 °C for 3
min, aniline was evaporated under vacuum, and the treated RNA was
dissolved in 10 l of water. To the aniline-treated and -untreated
samples, buffer containing 32% formamide, 4 mM EDTA, 0.04% xylene
cyanol, and 0.04% bromphenol blue was added. The samples were
heated at 65 °C for 5 min and analyzed on a 2% agarose gel. The RNA
was visualized by ethidium bromide staining.
Assay for in Vitro Protein Synthesis Inhibition—The capacity of sa-
porin and its mutants to inhibit protein synthesis was measured using
a rabbit reticulocyte lysate-based in vitro translation assay system. The
rabbit reticulocyte lysate was prepared, and the assay was carried out
as described (30). The reaction mix in a final volume of 30 l contained
10 l of rabbit reticulocyte lysate, 1 mM ATP, 0.2 mM GTP, 75 mM KCl,
2 mM magnesium acetate, 3 mM glucose, 10 mM Tris-HCl, pH 7.6, 4 M
amino acid mix without leucine, 0.16 Ci of [3H]leucine, 1.33 mg/ml
creatine phosphokinase, 2.66 mg/ml creatine phosphate, and different
concentrations of the toxin, diluted in 0.2% RNase-free bovine serum
albumin. The endogenous globin mRNA in the reticulocyte lysate was
used for translation. The reaction was carried out at 30 °C for 1 h and
stopped by adding 0.25 ml of 1 N NaOH containing 0.2% H2O2, followed
by an incubation at 37 °C for 10 min. The proteins were precipitated
with 15% trichloroacetic acid on ice for 30 min and harvested on 26-mm
glass fiber filters. The dried filters were counted using a liquid scintil-
lation counter. Activity was expressed as the percentage of control
where no toxin was added. ID50 represents the concentration of toxin
that inhibited in vitro protein synthesis by 50%.
Cytotoxic Activity of Saporin-6 and the Mutants—The cytotoxic ac-
tivity of saporin-6 and its mutants was assayed on four different cell
lines: U937 (human histiocyte lymphoma), L929 (mouse fibroblast),
J774A.1 (mouse monocyte-macrophage), and HUT102 (human cutane-
ous T-cell lymphoma). Adherent cells were plated at a density of 5 103
cells/well in a 96-well plate in 0.2 ml of RPMI/Dulbecco’s modified
Eagle’s medium containing 10% FCS for 16 h. The medium was re-
placed with 0.2 ml of leucine-free medium containing 2% FCS for
evaluating the cytotoxicity. The suspension cells were seeded at 104
cells/well in 0.2 ml of leucine-free medium containing 2% FCS and used
immediately. The cells were incubated with various concentrations of
toxins, diluted in 0.2% human serum albumin in Dulbecco’s PBS for
34 h followed by labeling with 0.75 Ci of [3H]leucine/well for 2 h. The
cells after freezing and thawing were harvested on filtermats using a
96-well plate automated harvester, and the filters were counted using
TABLE I
Sequence of primers used for mutagenesis of residues in saporin-6
The letters in lowercase represent the nucleotides mutated. The underlined sequence denotes the HindIII site created in the mutant through the
primer for screening.
Primer Mutant Sequence
JKB54 Y16A 5-ATCCACAAAAGATGAagcTTGACCCGCGGTCGG-3
JKB55 R24A 5-ATCCTTTACGTTGTTagcGATTTTATCCACAAA-3
JKB56 Y72A 5-AAGATACGCGACCACagcCAAGTTATCGCGTTT-3
JKB57 Y120A 5-CTTTTCGATTGACTGagcATCTTCTGTGTATTC-3
JKB58 E176A 5-CCTAAATCGTGCTACagcTGCTGTCATTTGAAT-3
JKB59 R179A 5-TTGAATGTACCTAAAagcTGCTACCTCAGCTGT-3
JKB60 W208A 5-CGTAGAAATCTTACGagcGCTGACTTCAAATTG-3
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an LKB -plate counter. Activity was plotted as percentage of control
where no toxin was added to the cells, and the results were expressed in
the form of ID50 values. The ID50 values represent the concentration of
the toxin that inhibited the cellular protein synthesis by 50%.
Assay for Genomic DNA Fragmentation—U937 cells were used to
evaluate genomic DNA fragmentation ability of saporin-6 and the mu-
tants. 5  105 cells were cultured in RPMI containing 10% FCS in the
presence of different concentrations of proteins. After the indicated time
of incubation, cells were harvested and lysed with 0.2 ml of lysis buffer
consisting of 10 mM Tris-Cl, pH 8.0, 100 mM NaCl, 25 mM EDTA pH 8.0,
0.5% SDS, and 0.1 mg/ml proteinase K at 50 °C for 16 h. The DNA was
extracted with phenol/chloroform and precipitated with isopropyl alco-
hol. After treating with RNase A, the DNA samples were run in a 1.5%
agarose gel and visualized by staining with ethidium bromide.
Intracellular Localization of Saporin—Saporin-6 was iodinated us-
ing the iodogen method as described by Harlow and Lane (31). 10 g of
protein (0.2–1.0 mg/ml in PBS), 25 l of iodination buffer, and 1 mCi of
Na125I were added to the iodogen-coated tube. The tube was tapped at
room temperature for 10 min followed by the addition of 50 l of 0.2%
KI. The labeled protein was purified using PD-10 column (Amersham
Biosciences) presaturated with bovine serum albumin.
J774A.1 cells, 6  106 were seeded in 6 ml of Dulbecco’s modified
Eagle’s medium containing 10% FCS in a T-25 tissue culture flask and
incubated at 37 °C for 16 h. The medium was replaced with 1 ml of
Dulbecco’s modified Eagle’s medium containing 2% FCS, and cells were
incubated for various time intervals with 100 l (107 cpm) of iodinated
saporin-6. After incubation, the cells were washed once with PBS and
further incubated for 1 h so that membrane-bound saporin-6 would
either dissociate or internalize. Cells were fractionated into nuclear,
cytosolic, and membrane fractions as described by Dignam et al. (32).
The cell pellet was resuspended in 500 l of buffer containing 10 mM
HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, and 1 g/ml leupep-
tin and incubated on ice for 10 min. The cells were centrifuged at
3000  g, resuspended in 0.5 ml of the same buffer, and homogenized
using a motor-driven homogenizer (30 strokes at 1500 rpm). The homo-
genate was checked microscopically for cell lysis and centrifuged for 10
min at 3000 g at 4 °C. The pellet constituted the nuclear fraction, and
the supernatant contained cytosol and membranes. To the supernatant,
0.11 volume of buffer containing 0.3 M HEPES, pH 7.9, 1.4 M KCl, and
0.03 M MgCl2 was added, and the mixture was centrifuged at 100,000 
g for 30 min at 4 °C in an ultracentrifuge. The supernatant and the
pellet constituted cytosolic and membrane fractions, respectively. The
nuclear and membrane pellets were resuspended in 500 l of PBS. The
proteins in various fractions were precipitated with 1 ml of 20% trichlo-
roacetic acid. The precipitated proteins were boiled in SDS loading dye
for 3 min and analyzed on a 12.5% SDS-polyacrylamide gel. The gel was
dried, exposed to an x-ray film, and later developed.
RESULTS AND DISCUSSION
The present study evaluates the role of various invariant
residues present in the ribosome-inactivating protein saporin-6
in its catalytic and cytotoxic activity. These include Tyr72,
Tyr120, Glu176, Arg179, and Trp208, which have been proposed to
be present in the active site and play an important role in the
catalysis (21). The role of two other invariant residues, Tyr16
and Arg24, proposed to be important for structural stability of
ricin (33), has also been studied. These residues were mutated
to alanine to generate seven single mutants, Y16A, R24A,
Y72A, Y120A, E176A, R179A, and W208A. The target residues
were substituted with alanine, since it does not impose new
hydrogen bonding, sterically bulky, or unusually hydrophobic
side chains (34).
Expression, Purification, and Structural Characterization of
Saporin-6 Mutants—The mutants of saporin-6 were expressed
in BL21 (DE3) strain of E. coli cells, and the overexpressed
mutant proteins were found to localize in the inclusion bodies
like the wild type protein. The recombinant proteins from the
inclusion bodies were denatured and refolded in vitro and
purified by a two-step purification scheme comprising a cat-
ion-exchange and gel filtration chromatography. By SDS-
PAGE analysis, the mutants gave a single band at the same
position as saporin-6, indicating the preparations to be ho-
mogeneous (Fig. 1). On Western blots, all of the mutants
reacted equally well with a polyclonal antibody raised
against saporin-6 (Fig. 1).
The effect of the mutation on the overall structure of sa-
porin-6 was studied by CD spectral analysis of purified mu-
tants in the far-UV region. Saporin-6 showed the spectra char-
acteristic of    structure (Fig. 2). The substitution of active
site residues Tyr72, Glu176, and Trp208 with alanine resulted in
a modest shift of the CD spectrum, whereas the mutants
Y120A and R179A appeared to have similar spectra as that of
saporin-6 (Fig. 2, A and B). The replacement of the invariant
residue Tyr16 with alanine resulted in a significant shift in the
CD spectra (Fig. 2C). The -helical content of the mutants
Y16A, Y72A, Y120A, E176A, R179A, and W208A was found to
be similar to that of saporin-6; however, there was a decrease in
-sheet content of these mutants compared with the native
toxin (Table II). The mutant R24A appeared to be similarly
folded as the native toxin (Fig. 2C). The quantitative values of
various secondary structure elements of R24A were found to be
similar to saporin-6 (Table II).
RNA N-Glycosidase Activity of Saporin-6 Mutants—The ef-
fect of substitution of various active site and invariant residues
with alanine on the specific RNA N-glycosidase activity of
saporin-6 was evaluated. Rabbit reticulocyte lysate was treated
with various concentrations of the mutants, and total RNA was
extracted. Half of the extracted RNA was treated with aniline,
and both aniline-treated and -untreated RNA samples were
run on an agarose gel. As shown in Fig. 3, aniline treatment of
saporin-6-treated RNA samples resulted in the release of the
classic 390-base Endo-fragment. Whereas saporin-6 produced
the endofragment at as low as 40 ng/ml, the mutants Y72A and
Y16A failed to affect rRNA even up to 1000 ng/ml (Fig. 3). With
the mutants Y120A, E176A, and R179A, a faint endofragment
was seen at 1000 ng/ml in the aniline-treated samples (Fig. 3).
FIG. 1. SDS-PAGE and Western blot analysis of saporin-6 and
the mutants. The proteins were expressed in BL21 (DE3) cells of
E. coli and purified from inclusion bodies by cation exchange and gel
filtration chromatography. The recombinant proteins were analyzed by
12.5% SDS-PAGE under reducing conditions, followed by Coomassie
Blue staining (A). Western blot analysis of the mutants was done using
a polyclonal antibody raised against saporin-6 (B). The different lanes
in B correspond to the same proteins as in A.
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Substitution of Trp208 or Arg24 with alanine did not have any
effect on the RNA N-glycosidase activity of saporin-6, since the
mutants W208A and R24A released the Endo-fragment from
28 S rRNA at concentrations similar to that of the native toxin
(Fig. 3). The intensity of endofragment increased with increas-
ing concentrations of the toxin, indicating a dose-dependent
response. The decrease in size of 28 S rRNA upon release of the
390-base fragment was also apparent in aniline-treated sam-
ples of the mutants W208A and R24A (Fig. 3).
The release of Endo-fragment from 28 S rRNA as a result of
saporin action results in potent inhibition of protein synthesis.
The ability of the saporin-6 mutants to inhibit protein synthe-
sis was tested in a rabbit reticulocyte lysate-based in vitro
translation assay. The decrease in the incorporation of
[3H]leucine in the nascent peptides was taken as the measure
of protein synthesis inhibition by the toxin. Saporin-6 caused a
dose-dependent inhibition of protein synthesis with an ID50 of
4.5 ng/ml (Table III). The mutations of Trp208 and Arg24 did not
affect the protein synthesis-inhibitory activity of saporin-6, and
mutants W208A and R24A also showed a dose-dependent in-
hibition of protein synthesis with respective ID50 values of 6.0
and 5.8 ng/ml (Table III). The substitution of invariant residue
Tyr16 and the active site residue Tyr72 with alanine abolished
the protein synthesis-inhibitory activity of the protein, and
even in the presence of 1000 ng/ml Y16A or Y72A, there was no
inhibition of protein synthesis (Table III). The mutants Y120A
and E176A, however, caused protein synthesis inhibition but at
a relatively higher concentration compared with the native
toxin. The respective ID50 values of Y120A and E176A were
480 and 100 ng/ml, showing these mutants to be 100- and
20-fold less active than the native toxin (Table III). The mutant
R179A showed an extremely poor protein synthesis inhibitory
activity; its ID50 was found to be 200-fold less than the native
toxin (Table III). The reduced protein synthesis-inhibitory ac-
tivity of the mutants is in agreement with the inability or
reduced activity of these mutants to generate the
Endo-fragment.
Thus, it appears that among the active site residues, Tyr72
and Arg179 are absolutely essential for the RNA N-glycosidase
activity of saporin-6. The residues Tyr120 and Glu176 can be
partially dispensed with, whereas Trp208 and Arg24 are not
required for the RNA N-glycosidase activity. The invariant
residue Tyr16 also appears to be critical for the RNA N-glyco-
sidase activity of saporin-6.
The three-dimensional structure reveals the active site res-
idues, Glu176, Arg179, and Trp208, of saporin-6 to be completely
superimposable on those of other RIPs (21). However, the res-
idue Tyr72, shown to be responsible for the interaction with the
target adenine, assumes different side chain conformations
among all analyzed RIPs.
The role of active site residues of ricin Tyr80, Tyr123, Glu177,
and Arg180, equivalent to Tyr72, Tyr120, Glu176, and Arg179 in
saporin, has been studied earlier (22, 35–37). Tyr80 in ricin has
been shown to make the firmest physical contact with adenine
and is more crucial to substrate recognition than Tyr123 (22). In
ricin, although Glu177 is proposed to be essential for transition
state stabilization, its substitution with alanine facilitates the
nearby Glu208 to move into the active site and fulfill a role
similar to that of Glu177 (35, 36). The complete loss of activity
of saporin-6 mutant Y72A and a partial loss in activity of
Y120A indicate a similar mechanism of action in saporin-6 and
ricin. Compared with saporin-6, a 20-fold reduction was ob-
served in the activity of E176A mutant. It appears that in the
mutant E176A, Glu205 occupies the position of Glu176; however,
carboxylate of Glu205 in the saporin-6 mutant E176A may
provide less stabilization to the oxycarbonium ion transition
state than Glu176. The mutation of Arg179 to alanine reduced
the protein synthesis-inhibitory activity of saporin-6 by 200-
fold. Arg180, corresponding to Arg179 of saporin-6, has been
shown in ricin to lie parallel to the conserved Trp211 residue,
Trp208, in saporin-6 and make strong hydrogen bonds with
O-78 of the protein backbone, Glu177 and an active site water
that may be involved in the RNA N-glycosidase reaction (37).
This conserved arginine may also bind to the phosphate back-
bone of the 28 S rRNA substrate. A similar mechanism seems
to be operative in saporin-6 also.
The mutation of the only tryptophan residue of saporin-6 to
alanine did not affect the enzymatic activity of the protein.
Studies on pokeweed antiviral protein and abrin have sug-
gested that Trp208 and Trp198, respectively, in these proteins,
FIG. 2. CD spectral analysis of saporin-6 and the mutants. CD spectra were recorded in the far-UV region (200–250 nm) at 25 °C, and the
spectra are presented as the mean residue ellipticity. A, saporin-6 (solid line), Y72A (dotted and dashed line), and Y120A (dotted line). B, saporin-6
(solid line), E176A (dotted and dashed lines), R179A (dotted line), and W208A (dashes and double dots). C, saporin-6 (solid line), Y16A (dotted and
dashed line), and R24A (dotted line).
TABLE II
Secondary structure analysis of saporin-6 and the mutants
CD spectra of the proteins were acquired at a scan speed of 50 nm/min
with a senstivity of 50 millidegrees and a response time of 1 s. Yang’s
reference parameters were used to perform secondary structure analy-
sis from CD measurements.
Protein -Helix -sheet Turn Random
Saporin-6 14.3 42.8 13.4 29.5
Y16A 20.7 21.6 20.6 37.1
R24A 12.8 41.1 13.5 32.6
Y72A 17.8 29.4 20.4 32.3
Y120A 17.0 32.2 19.5 31.3
E176A 15.7 33.8 17.8 32.7
R179A 19.1 25.7 21.5 33.7
W208A 19.5 23.0 20.7 36.8
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corresponding to Trp208 in saporin-6, are crucial for structural
integrity of these proteins (38, 39).
Tyr16 and Arg24 are two of the nine invariant residues out-
side of the active site conserved among various RIPs (33).
Whereas mutation at Tyr16 to alanine resulted in complete loss
of activity, mutating Arg24 did not have any effect on the
enzymatic activity of saporin-6. Studies with trichosanthin
have suggested that the residues Tyr14 and Arg22, correspond-
ing to Tyr16 and Arg24 of saporin-6, interact with the residues
on the adjacent helix, which contains the active site residues
Glu160 (Glu176 of saporin-6) and Arg163 (Arg179 of saporin-6)
(40). The mutation of Tyr14 to Phe resulted in only a 5-fold
decrease in activity (40). In ricin A-chain, deletion of residues
21–23 (thereby deleting Tyr21, equivalent to Tyr16 in saporin-6)
did not affect the functional activity of the protein (41). These
observations suggest that conserved Tyr at this position is not
absolutely essential for the activity of RIPs. However, mutation
of Tyr16 in saporin-6 to alanine resulted in complete loss of the
RNA N-glycosidase activity.
Cytotoxic Activity of Saporin-6 Mutants—A variety of cancer
cell lines were treated with different concentrations of sa-
porin-6 or the mutants, and protein synthesis inhibition in the
cells was taken as the measure of cytotoxicity. Saporin-6
caused a dose-dependent toxicity to all of the cell lines. J774A.1
was the most sensitive cell line, followed by L929, HUT 102,
and U937 (Table IV). On J774A.1 cells, the mutant R24A had
toxicity similar to that of saporin-6, and the mutant E176A had
about 15-fold reduced activity (Table IV). Although mutants
W208A and Y16A were toxic to J774A.1 cells, compared with
saporin-6 they had about 200-fold lower activity (Table IV).
Mutants Y120A and R179A manifested an extremely poor cy-
totoxicity on J774A.1 cells (Table IV). The mutant Y72A was
totally nontoxic to J774A.1 cells. A similar pattern of cytotox-
icity was observed with all of the mutants on the other three
cell lines also, however, the extent of toxicity and the -fold
difference between saporin and various mutants varied with
different cell lines (Table IV). The effect of various mutants on
J774A.1 cells closely matched with that on U937 cells (Table
IV).
The protein synthesis-inhibitory activity of all the mutants
correlated well with their ability to release the Endo-fragment.
A comparison of the cytotoxicity and enzymatic activities, in
vitro translation inhibition, and production of the endofrag-
ment revealed the two activities for mutants R24A, Y72A,
Y120A, E176A, and R179A to be in complete correlation (i.e.
the mutants having in vitro protein synthesis inhibitory activ-
ity and the Endo-fragment release activity demonstrated cyto-
toxicity). The extent of cytotoxicity corresponded quantitatively
to the enzymatic activities of the mutants. Saporin-6 and the
mutant R24A showed similar enzymatic activities and similar
cytotoxicities on all of the cell lines. Y72A did not have any
enzymatic activity and lacked cytotoxicity as well. E176A
showed 1–25% cytotoxic activity of the native toxin (Table IV),
consistent with its partial enzymatic activity. Y120A also
showed partial cytotoxicity, agreeing with its reduced enzy-
matic activity. R179A was found to be partially active in the
Endo-fragment assay and had significantly less cytotoxicity.
Interestingly, for the mutants Y16A and W208A, there was no
correlation between their cytotoxic activity and enzymatic ac-
tivities. The activity of the mutant W208A was found to be
similar to that of saporin-6 in both in vitro protein synthesis
inhibitory assay and Endo-fragment release assay; however, its
cytotoxicity was found to be significantly lower than the native
toxin. On the other hand, the mutant Y16A was found to be
inactive in both protein synthesis inhibition assay and Endo-
fragment release assay, yet it showed partial cytotoxicity on all
FIG. 3. Specific RNA N-glycosidase activity of saporin-6 and the mutants on 28 S rRNA. Rabbit reticulocyte lysate was treated with
various proteins at the indicated concentrations. The reaction was carried at 30 °C for 30 min followed by termination of the reaction using 0.4%
SDS. Total RNA was extracted, and half of it was treated with aniline acetate at 60 °C for 3 min. Following vacuum drying, the aniline-treated
() and -untreated () RNA was resolved by electrophoresis on 2% agarose gel.
TABLE III
In Vitro protein synthesis inhibitory activity of saporin-6
and the mutants
Rabbit reticulocyte lysate was treated with various concentrations of
saporin-6 or the mutant at 30 °C for 1 h. ID50 values refer to the
concentration of toxin causing 50% inhibition of protein synthesis.
Protein ID50
(ng/ml)
Saporin-6 4.5
Y16A 1000.0
R24A 5.8
Y72A 1000.0
Y120A 480.0
E176A 100.0
R179A 1000.0
W208A 6.0
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of the cell lines tested. Thus, it appeared that cytotoxicity of
saporin-6 is not solely the consequence of its RNA N-glycosi-
dase activity, and other activities or factors may also be
involved.
Effect of Saporin-6 and Its Mutants on Genomic DNA—For
almost two decades it was largely assumed that RIPs act only
on rRNA within ribosomes (3, 42). Recently, however, all plant
RIPs and Shiga toxin have been shown to remove several
adenine residues from naked RNAs and from DNA in vitro (9,
43, 44). Some RIPs have been shown to possess direct DNase
activity also (24, 45). There has been a proposal to replace the
term “ribosome-inactivating protein” with “polynucleotide:ad-
enosine glycosidase” (9). This has raised great interest in the
study of the mechanism of action of RIPs on intact cells, to
investigate the potential contribution of various activities of
RIPs to their cytotoxicity.
The effect of saporin-6 was monitored on the genomic DNA of
U937 cells in an attempt to ascertain the contribution of this
activity to the cytotoxicity. U937 cells were incubated with 0.1
and 1 M of saporin-6 for various time intervals (Fig. 4A). In the
presence of 1 M saporin-6, significant DNA fragmentation
started within 24 h of incubation and became more pronounced
at 36 and 48 h. The control, where no toxin was added, showed
a high molecular weight genomic DNA band throughout the
course of study (Fig. 4A). With 0.1 M toxin there was no
laddering after 24 h; however, in 36 h faint small molecular
weight bands could be seen, and a further 12-h incubation
resulted in a laddered appearance of the genomic DNA (Fig.
4A). In order to investigate the effect of mutations of active site
residues and invariant residues in saporin-6 on its ability to
fragment genomic DNA, U937 cells were incubated in the pres-
ence of 1 M mutant proteins for 48 h. The genomic DNA was
isolated and analyzed on agarose gels. As shown in Fig. 4B, the
active site mutants Y72A, Y120A, E176A, R179A, and W208A
failed to affect the genomic DNA. The cells treated with these
proteins showed a high molecular weight intact DNA band as
seen in the control. However, with mutants Y16A and R24A,
fragmented DNA was obtained similar to that with the native
saporin-6 (Fig. 4B).
Table V summarizes the RNA N-glycosidase activity, cyto-
toxicity, and genomic DNA fragmentation activity of saporin-6
mutants. The activity of all the mutants on genomic DNA did
not correlate with their RNA N-glycosidase activity. The wild
type saporin-6 and the mutant R24A showed similar RNA
N-glycosidase activity, cytotoxicity, and genomic DNA frag-
mentation activity. The mutant Y72A did not show any RNA
N-glycosidase activity and cytotoxicity, and did not cause any
genomic DNA fragmentation. The mutants Y120A, E176A, and
R179A had no DNA fragmentation activity; however, they
showed partial RNA N-glycosidase activity and poor cytotoxic
activity. The mutant W208A possessed full RNA N-glycosidase
FIG. 4. Genomic DNA laddering by saporin-6 and the mutants.
DNA was isolated from equal number of U937 cells treated with sa-
porin-6 or the mutant. The samples were run on 1.5% agarose gel and
visualized by staining with ethidium bromide. A, genomic DNA profile
after treatment of U937 cells with saporin-6 for indicated time and
concentration; B, genomic DNA isolated from U937 cells after treat-
ment with 1 M mutant protein for 48 h.
TABLE IV
Cytotoxic activity of saporin-6 and the mutants
Cells were treated with different concentrations of saporin-6 or the mutants for 36 h. Incorporation of [3H]leucine in the newly synthesized
proteins was measured. ID50 refers to the amount of toxin required to inhibit cellular protein synthesis by 50%. The numbers in parenthesis
indicate percentage activity compared with the native toxin.
Protein
ID50
J774A.1 HUT102 L929 U937
g/ml
Saporin 0.02 (100) 3.0 (100) 0.6 (100) 4.5 (100)
Y16A 4.00 (0.50) 27.0 (11) 37.0 (1.6) 32.0 (14)
R24A 0.02 (100) 1.4 (200) 1.8 (33.4) 6.4 (70)
Y72A 100 (0.02) 100.0 (3) 100.0 (0.6) 86.0 (5)
Y120A 100.00 (0.02) 100.0 (3) 50.0 (1.2) 28.0 (16)
E176A 0.30 (6.0) 12.0 (25) 55.0 (1.1) 45.0 (10)
R179A 18.00 (0.10) 100.0 (3) 100.0 (0.6) 100.0 (4.5)
W208A 3.00 (0.70) 25.0 (12.0) 40.0 (1.5) 21.0 (21.5)
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activity and had reduced cytotoxicity but failed to affect the
genomic DNA. The mutant Y16A did not show any RNA
N-glycosidase activity and possessed reduced cytotoxicity sim-
ilar to that of W208A; however, it caused the genomic DNA
fragmentation comparable with native saporin-6. These results
clearly demonstrate that saporin-6 possesses two independent
activities (namely RNA N-glycosidase activity and genomic
DNA fragmentation activity), and both are required for the
cytotoxicity of the toxin.
Role of RNA N-Glycosidase and Genomic DNA Fragmenta-
tion Activity in Saporin-6 Cytotoxicity—The cytotoxicity data of
various mutants indicated that for complete cytotoxic activity
of saporin-6 both RNA N-glycosidase and genomic DNA frag-
mentation activities are required (Table V). Loss of either one
of these activities resulted in a reduction or loss of the cytotoxic
activity. The mutants Y16A and W208A each possessed one of
the two activities, DNA fragmentation activity and rRNA
N-glycosidase activity, respectively, and showed similar but
much reduced cytotoxicities (Table V).
In order to further confirm the contribution of the two enzy-
matic activities of saporin-6 to its cytotoxic activity, U937 and
J774A.1 cells were treated with various concentrations of
Y16A, W208A, and an equimolar mixture of the two proteins.
As mentioned before, Y16A and W208A showed a comparable,
about 6-fold lower, cytotoxic activity than saporin-6 on U937
cells, and on J774A.1 cells they had 230- and 125-fold less
activity (Table VI). An equimolar mixture of Y16A and W208A
resulted in the cytotoxicity very similar to that of saporin-6 on
U937 cells, whereas the mixture had a 5- and 3-fold improved
cytotoxicity compared with that of the individual mutant pro-
teins on J774A.1 cells (Table VI). The cytotoxicity of saporin-6,
therefore, appears to be a combined effect of its RNA N-glyco-
sidase and DNA fragmentation activities.
Intracellular Localization of Saporin-6—To investigate
whether saporin translocates to nucleus to degrade DNA,
J774A.1 cells were treated with iodinated saporin-6 for 3, 6, 9,
and 16 h, and the presence of radiolabeled protein was checked
in the nuclear, cytosolic, and membrane fractions. As shown in
Fig. 5, the concentration of saporin-6 increased in cytosol up to
6 h, decreased gradually, and became negligible by 16 h. The
membrane fraction did not show any significant amount of
protein at any time point. The concentration of the protein in
nuclear fraction was found to be comparable with that in the
cytosolic fraction up to 9 h; however, by 16 h, concomitant with
the decrease in cytosol, most of the labeled saporin-6 localized
in the nucleus (Fig. 5). Apart from the intact 30-kDa sa-
porin-6 band, the nuclear fraction also showed some low mo-
lecular mass bands of 17 and 25 kDa, seen earlier in the
membrane fraction, indicating onset of degradation of sa-
porin-6 at longer incubation periods (Fig. 5). The study shows
that after internalization initially the protein stays in the cy-
tosol and later migrates to the nucleus. Studies with Shiga
toxin have shown that internalized Shiga toxin-I reaches the
nuclear envelope, and the cells treated with Shiga toxin show
the toxin predominantly in the nuclear fraction (46, 47).
Saporin-6 does not possess any apparent nuclear localization
signal. It appears that the primary target inside the cell is
FIG. 5. Intracellular localization of radiolabeled saporin-6. J774A.1 cells were incubated with radiolabeled saporin-6 for the indicated time
points, and cells were washed and incubated further for 1 h. The cells were homogenized and separated into the nuclear, cytosolic, and membrane
fractions by ultracentrifugation. Proteins were precipitated from the cytosolic and membrane fractions using 20% trichloroacetic acid, the samples
were analyzed by 12.5% SDS-PAGE followed by autoradiography. H, total homogenate; N, nuclear fraction; C, cytosol; M, membrane fraction.
TABLE V
Comparison of various activities of saporin-6 and the mutants
Translation inhibition is expressed as percentage of activity of the native toxin. Cytotoxic activity is shown for U937 cells. P. Active, partially
active as compared with the native toxin.
Protein Translationinhibition
Endo-fragment
release Cytotoxicity
DNA
fragmentation
Saporin-6 100.00 Active  
Y16A 0.45 Inactive  
R24A 78.00 Active  
Y72A 0.45 Inactive  
Y120A 1.00 P. Active / 
E176A 4.50 P. Active  
R179A 0.45 P. Active / 
W208A 75.00 Active  
TABLE VI
Cytotoxic activity of Y16A, W208A, and saporin-6
U937 and J774A.1 cells were treated with various concentrations of
saporin, Y16A, and W208A and an equimolar mixture of Y16A and
W208A for 36 h. Incorporation of [3H]leucine was measured in the
newly synthesized protein. ID50 refers to the concentration of toxin
causing 50% inhibition of protein synthesis compared with controls
where no toxin was added.
Protein
ID50
U937 J774A.1
g/ml
Saporin 5.2 0.08
W208A 32.0 10.0
Y16A 32.0 19.0
W208A and Y16A 9.0 3.8
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rRNA and that activity on genomic DNA is a late event in
cytotoxicity.
Recent studies on ricin and Shiga toxin suggest that these
RIPs can damage nuclear DNA in whole cells by means that are
not secondary to ribosome inactivation (48). Shiga toxin has
been shown to release adenine from DNA by its RNA N-glyco-
sidase activity that leads to spontaneous break of sugar-phos-
phate backbone, whereas saporin-6, dianthin-30, and gelonin
have been reported to manifest direct DNase-like activity on
plasmid DNA (24, 49). The key residues involved in the cata-
lytic activity of saporin appear to be functionally similar to
homologous residues in ricin A and other RIPs. The current
study demonstrates that the DNA fragmentation observed is
not entirely dependent on the RNA N-glycosidase activity. The
comparison of activities of saporin-6 mutants also suggests that
there is a considerable overlap between the residues required
for RNA N-glycosidase activity and genomic DNA fragmenta-
tion activity. Tyr72, Tyr120, Glu176, and Arg179 are important for
the activity on both DNA and rRNA. Trp208 appears to be
required only for the genomic DNA fragmentation activity.
Substitution of Tyr16 abolished the activity of protein on rRNA;
however, it did not affect the genomic DNA fragmentation
activity. The residue Arg24 can be dispensed with for both of the
activities of saporin-6. The crystal structure of saporin-6 and
superimposition of the structure with other RIPs has suggested
that the loop between its 7 and 8 strands is particularly
short, and it makes active site more accessible to various dif-
ferent adenine-containing substrates (21). Therefore, it ap-
pears that saporin-6 binds to DNA and rRNA through the same
active site; however, the local positioning of the two substrates
could be different, enabling different residues to interact. The
cytotoxic activity appears to require both the activities, and
loss or reduction of one results in a loss or reduction in the
cytotoxic activity of saporin.
In conclusion, we have shown that saporin-6 possesses two
catalytic activities, namely RNA N-glycosidase and genomic
DNA fragmentation activity. The cytotoxic activity of saporin-6
is governed by both of these activities, which share consider-
able overlap in terms of amino acid residue requirement. Tyr72
and Arg179 are absolutely indispensable for RNA N-glycosidase
as well as genomic DNA fragmentation activity, whereas Arg24
does not seem to be playing any role in any of these activities of
saporin-6. Tyr120, Glu176, and Trp208 play an important role in
DNA fragmentation activity. However, Trp208 could be dis-
pensed with completely, and Tyr120 and Glu176 partially, for
the RNA N-glycosidase activity. Tyr16 appears to be required
for the maintenance of a conformation essential for RNA
N-glycosidase activity.
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